MédiMabs Clones
A blog about science
Beyond Irreversibility: Restoring the Brain’s Recycling Fleet to Combat Alzheimer’s Disease
While prior studies report NAD+ depletion in Alzheimer’s disease (AD) models and partial attenuation of pathology with NAD+ precursor supplementation (1), the “more is better” approach has its limits. High doses of NAD+ precursors can produce supraphysiologic levels that may promote cancer, making them a risky long-term solution. In a recent study in Cell Reports […]
Latest articles
TLR4, 20 years later
20 years ago, in 1998, two research groups, Bruce Beutler’s and Shizuo Akira’s, have identified TLR4 as the LPS (Lipopolysaccharide)...
MédiMabs’ Team • Oct 31 • 2 minutes read
Akt activation pathway
Akt is a subfamily of serine/threonine kinases (Protein Kinase B) that includes AKT1, AKT2, and AKT3. Akt resides in the...
MédiMabs’ Team • Oct 26 • 2 minutes read
IDIGH symposium and product show
(IDIGH) has been developed at McGill University to maximize the research effort with a translational focus. We are proud to...
MédiMabs’ Team • Oct 18 • 2 minutes read
Montreal Immunology Meetings
Montreal Immunology Meetings are a local initiative from researchers in immunology related fields. They organize small presentations from experts on...
MédiMabs’ Team • Oct 12 • 1 minutes read
DDRs, a family of 2 proteins, are key in cell-to-microenvironment communication
The cellular microenvironment can modulate intracellular pathways, these interactions can occur in normal or physiopathological conditions. However, if pro-survival molecules...
MédiMabs’ Team • Oct 03 • 2 minutes read
MédiMabs is presenting StabiliMABS
StabiliMABS is a two part option you can apply on any custom hybridoma project. We would first apply StabiliMABS-1 on early positive clones...
MédiMabs’ Team • Sep 27 • 2 minutes read
EGFRs in cancer
Epithelial Growth Factor Receptors are a family of receptor tyrosine kinase well studied for their role in cancer. (1) They have been...
MédiMabs’ Team • Sep 27 • 2 minutes read
SOD1 and ALS
The discovery of the implication of in familial ALS has turned 25 this year.(1) ALS was discovered more than 100 years ago...
MédiMabs’ Team • Sep 19 • 2 minutes read
CRCHUM show October 11th 2018
It will be our pleasure to meet you at our booth during the event on October 11th at the CRCHUM in Montréal. We will...
MédiMabs’ Team • Sep 19 • 1 minutes read
Neurosciences
Research on neurodegenerative disease has always been important at MédiMabs. Partly because two of our founders have dedicated their career to this...
MédiMabs’ Team • Sep 19 • 1 minutes read
